샘플 요청 목록

 카트 문의
시장보고서
상품코드
1993837

뇌혈관조영술 시장 : 영상 진단 기술별, 용도별, 환자 연령별, 적응증별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Cerebral Angiography Market, By Imaging Technique, By Application, By Patient Age, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 295 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뇌혈관조영술 시장 규모는 2025년에 13억 5,891만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 6.70%로 확대될 것으로 전망됩니다.

뇌혈관조영술은 조영제를 동맥계에 주입하여 X선 영상을 획득하여 뇌혈관을 가시화하는 영상 진단 기술로, 임상의가 동맥류, 동정맥 기형, 폐색 등 혈관 이상을 고해상도 및 고정밀도로 검출할 수 있게 해줍니다. 그 용도는 뇌혈관계의 상세한 평가에 이르기까지 다양하며, 치료 계획이나 혈관 내 치료에 통합되는 경우가 많습니다. 공중 보건의 관점에서 볼 때, 정부 및 국제 보건기구의 권위 있는 데이터에 따르면 뇌혈관 질환, 특히 뇌졸중은 큰 건강 부담이 되고 있으며, 이는 고급 신경혈관 영상에 대한 수요의 주요 요인으로 작용하고 있습니다. 뇌졸중은 세계보건기구(WHO)에 의해 전 세계적으로 주요 사망 및 장애의 원인 중 하나로 인식되고 있으며, 그 발생률과 유병률은 여전히 높은 수준으로 의료 시스템과 임상 경로에서 정확한 혈관 영상이 핵심적인 역할을 하고 있음을 뒷받침하고 있습니다.

뇌혈관조영술 시장 - 시장 역학

전 세계 뇌졸중 및 뇌혈관 질환의 부담 증가 추세

뇌졸중 및 기타 뇌혈관 질환의 유병률 증가는 뇌혈관조영술에 대한 수요를 뒷받침하는 주요 요인입니다. 뇌혈관조영술은 뇌 속 혈관을 시각화하여 뇌졸중을 유발할 수 있는 동맥류, 혈관 기형, 동맥 막힘 등의 이상을 진단하는 데 널리 활용되고 있습니다. 전 세계적으로 뇌졸중 환자 수가 증가함에 따라, 의료 시스템에서는 정확한 진단과 치료 계획 수립을 지원하기 위해 보다 정교한 영상 진단법이 요구되고 있습니다. 정부 및 공중보건 통계에 따르면, 뇌졸중은 전 세계적으로 큰 부담으로 작용하고 있습니다. 세계보건기구(WHO)에 따르면, 전 세계적으로 수백만 건의 새로운 뇌졸중 사례가 발생하고 있으며, 약 수백만 명이 뇌졸중을 앓고 있습니다. 또한, 성인 4명 중 1명이 일생에 한 번은 뇌졸중을 경험할 것으로 예측하고 있으며, 신경질환 치료에 있어 영상 진단의 필요성이 증가하고 있음을 강조하고 있습니다. 뇌혈관조영술은 뇌혈관의 상세한 영상을 제공하기 때문에 병원이나 신경혈관센터에서는 혈관 이상 확인 및 중재시술 계획 수립에 점점 더 많이 활용하고 있습니다. 각국의 보건의료 통계에서 뇌졸중 및 관련 혈관 질환의 발생률이 지속적으로 보고되고 있는 가운데, 정확한 신경혈관 영상 진단 기술에 대한 요구가 높아짐에 따라 의료기관의 뇌혈관조영술 시스템 도입이 가속화될 것으로 보입니다.

뇌혈관조영술 시장 - 시장 세분화 분석:

세계 뇌혈관조영술 시장은 영상 진단 기술, 응용 분야, 환자 연령, 적응증, 최종사용자, 지역별로 세분화되어 있습니다.

시장 프레임워크는 영상 진단 기술을 기반으로 디지털 서브트랙션 앤지오그래피(DSA), 자기공명 앤지오그래피(MRA), 컴퓨터 단층촬영 앤지오그래피(CTA), 카테터 앤지오그래피(CTA), 카테터 앤지오그래피의 네 가지 부문을 식별합니다. 디지털 서브트랙션 앤지오그래피(DSA)는 뇌혈관의 매우 상세한 실시간 영상을 제공할 수 있기 때문에 뇌혈관조영술 시장에서 주요 부문을 차지하고 있으며, 특히 동맥류, 동정맥 기형 및 혈관 협착을 식별하는 데 유용합니다. 자기공명혈관조영술(MRA)이나 컴퓨터단층촬영혈관조영술(CTA)과 같은 비침습적 방법이 널리 보급되고 있지만, DSA는 여전히 복잡한 사례나 수술 계획에서 필수적인 역할을 하고 있습니다. 공중 보건 지침도 그 사용을 지지하고 있습니다. 미국심장협회(AHA)는 미국에서 매년 약 10만 건의 뇌졸중이 발생한다고 보고하며, 정확한 혈관 영상 촬영의 필요성을 강조하고 있습니다. 또한, 영국 국민보건서비스(NHS)는 중재적 치료 중 정확한 혈관 매핑이 필요한 경우 DSA를 권장하고 있습니다. 이러한 요인들이 결합되어 임상 현장에서 DSA의 지속적인 중요성을 강조하고 있습니다.

시장 구조는 용도에 따라 신경학, 신경외과, 중재적 방사선학의 세 가지 부문으로 분류됩니다. 신경학 분야는 뇌혈관조영술 시장에서 중요한 부문으로 부상하고 있습니다. 이는 뇌졸중, 동맥류, 동정맥 기형 등 뇌혈관 질환의 진단 및 경과 관찰에 널리 활용되고 있기 때문입니다. 뇌혈관조영술은 신경과 전문의에게 뇌혈관의 상세한 영상을 제공하여 신경혈관 질환의 신속한 진단과 효과적인 관리를 돕습니다. 이상 징후를 조기에 발견하는 것이 합병증을 예방하는 열쇠입니다. 공중 보건 데이터는 이러한 필요성을 뒷받침합니다. 미국 질병예방통제센터(CDC)의 보고에 따르면, 미국에서는 매년 수백만 명이 뇌졸중을 앓고 있으며, 그 중 약 수십만 명은 초발성 뇌졸중입니다. 한편, 세계보건기구(WHO)는 뇌혈관 질환이 전 세계적으로 수백만 명의 사망원인이 되고 있다고 지적하고 있습니다. 이러한 수치는 임상 진료와 공중 보건 계획 모두에서 신경 영상 진단의 중요성을 강조하며, 뇌혈관조영술의 수요를 주도하는 주요 응용 분야로서 신경학의 중요성을 뒷받침합니다.

뇌혈관조영술 시장 - 지역별 동향

세계 뇌혈관조영술 시장에서 북미와 아시아태평양은 의료 인프라, 질병 유병률, 기술 도입 현황의 차이로 인해 눈에 띄는 선두주자입니다. 북미는 첨단 의료 시스템, 신경 영상 진단 기술의 광범위한 보급, 뇌혈관 질환 진단 및 치료에 대한 막대한 투자에 힘입어 약 41.8%로 가장 큰 점유율을 차지하고 있습니다. 미국과 캐나다의 높은 뇌졸중 발생률과 CT 및 MRI 스캐너의 광범위한 사용으로 인해 상세한 혈관 영상 진단에 대한 수요가 계속 증가하고 있습니다. 아시아태평양은 현재 점유율은 작지만, 중국, 인도 등의 국가에서 의료 인프라 확충, 뇌졸중 및 신경혈관 질환에 대한 인식의 증가, 그리고 고급 진단에 대한 접근성 향상을 위한 정부의 노력으로 인해 빠른 성장세를 보이고 있습니다. 이는 방대한 인구와 늘어나는 뇌졸중 환자 수에 힘입은 바 큽니다. 이러한 추세는 의료 시스템, 질병 부담, 공공 부문의 지원이 지역별로 뇌혈관조영술의 도입과 확대에 어떤 영향을 미치고 있는지를 잘 보여줍니다.

뇌혈관조영술 시장 - 국가별 인사이트

전 세계적으로 미국은 첨단 신경 영상 진단 도구의 도입과 상세한 혈관 진단에 대한 니즈에 힘입어 뇌혈관조영술 시장에서 확고한 입지를 유지하고 있습니다. 우리나라는 뇌졸중 및 기타 뇌혈관 질환으로 인한 상당한 질병 부담에 직면해 있습니다. 미국 질병예방통제센터(CDC)의 보고에 따르면, 미국에서는 매년 수십만 명이 뇌졸중을 앓고 있으며, 그 중 약 수십만 명이 초발성 뇌졸중이라고 합니다. 그 중 약 87%는 허혈성 뇌졸중이며, 효과적인 치료를 위해서는 정밀한 영상 진단이 필요합니다. 이러한 수치는 뇌혈관의 이상을 감지하고 임상적 판단을 돕기 위해 뇌혈관을 세밀하게 시각화하는 뇌혈관조영술에 대한 높은 수요를 보여줍니다. 미국은 높은 질병 유병률, 우수한 의료 인프라, 첨단 영상 진단 시스템에 대한 접근성이 결합되어 세계 시장에서 선도적인 위치를 확고히 하고 있습니다.

목차

제1장 뇌혈관조영술 시장 개요

제2장 주요 요약

제3장 뇌혈관조영 주요 시장 동향

제4장 뇌혈관조영 산업 분석

제5장 뇌혈관조영술 시장 : 높아지는 지정학적 긴장의 영향

제6장 뇌혈관조영술 시장 구도

제7장 뇌혈관조영술 시장 : 영상 진단 기술별

제8장 뇌혈관조영술 시장 : 용도별

제9장 뇌혈관조영술 시장 : 환자 연령별

제10장 뇌혈관조영술 시장 : 적응증별

제11장 뇌혈관조영술 시장 : 최종사용자별

제12장 뇌혈관조영술 시장 : 지역별

제13장 주요 벤더 분석 : 뇌혈관조영 산업

제14장 AnalystView 전방위 전망

KSM 26.04.15

Cerebral Angiography Market size was valued at US$ 1,358.91 Million in 2025, expanding at a CAGR of 6.70% from 2026 to 2033.

Cerebral angiography is a diagnostic imaging technique in which a contrast agent is introduced into the arterial system and X ray images are acquired to visualize the blood vessels of the brain, enabling clinicians to detect vascular abnormalities such as aneurysms, arteriovenous malformations, and occlusions with high resolution and precision. Its application extends to a detailed assessment of cerebral vasculature and is often integrated into treatment planning and endovascular interventions. At the public health level, authoritative government and global health data indicate that cerebrovascular diseases, particularly stroke, constitute a substantial health burden and a key driver of demand for advanced neurovascular imaging; stroke is recognized by the World Health Organization as one of the leading causes of death and disability globally, demonstrating persistent incidence and prevalence that reinforce the central role of accurate vascular imaging in health systems and clinical pathways.

Cerebral Angiography Market- Market Dynamics

Increasing Global Burden of Stroke and Cerebrovascular Diseases

The rising prevalence of stroke and other cerebrovascular conditions is a major factor supporting the demand for cerebral angiography procedures. Cerebral angiography is widely used to visualize blood vessels in the brain and diagnose abnormalities such as aneurysms, vascular malformations, and arterial blockages that can lead to stroke. As the number of stroke cases increases globally, healthcare systems require more advanced imaging procedures to support accurate diagnosis and treatment planning. Government and public health statistics indicate a significant global burden of stroke. According to the World Health Organization (WHO), millions of new stroke cases occurred worldwide, and about millions of people were living with stroke globally. The organization also reports that one in four adults is expected to experience a stroke during their lifetime, highlighting the growing need for diagnostic imaging in neurological care. Because cerebral angiography provides detailed images of cerebral blood vessels, hospitals and neurovascular centers increasingly use it for confirming vascular abnormalities and planning interventional procedures. As the incidence of stroke and related vascular disorders continues to be reported in national health statistics, the need for accurate neurovascular imaging technologies is likely to support the adoption of cerebral angiography systems in healthcare facilities.

Cerebral Angiography Market- Segmentation Analysis:

The Global Cerebral Angiography Market is segmented on the basis of Imaging Technique, Application, Patient Age, Indication, End User, and Region.

The market framework identifies four segments based on imaging technique: Digital Subtraction Angiography (DSA), Magnetic Resonance Angiography (MRA), Computed Tomography Angiography (CTA), and Catheter Angiography. Digital Subtraction Angiography (DSA) continues to represent a key segment in the cerebral angiography market due to its ability to provide highly detailed, real-time images of brain blood vessels, making it particularly useful for identifying aneurysms, arteriovenous malformations, and vascular narrowing. While non-invasive techniques such as Magnetic Resonance Angiography (MRA) and Computed Tomography Angiography (CTA) are gaining popularity, DSA remains essential for complex cases and surgical planning. Public health guidance supports its use: the American Heart Association reports approximately lakhs of strokes in the U.S. each year, emphasizing the need for precise vascular imaging, and the UK's National Health Service recommends DSA for cases requiring accurate vascular mapping during interventions. These factors collectively underscore DSA's continued prominence in clinical practice.

The market framework identifies three segments based on application: Neurology, Neurosurgery, and Interventional Radiology. The Neurology segment emerges as a significant segment in the cerebral angiography market, as it is widely used to diagnose and monitor cerebrovascular conditions such as stroke, aneurysms, and arteriovenous malformations. Cerebral angiography provides neurologists with detailed images of brain blood vessels, supporting timely diagnosis and effective management of neurovascular disorders, with early detection of abnormalities being key to preventing complications. Public health data underscores this need: the Centre for Disease Control and Prevention (CDC) reports that people in the U.S. experience a stroke each year, including approximately lakhs of first-time cases, while the World Health Organization (WHO) notes that cerebrovascular diseases cause over millions of deaths globally. These figures highlight the importance of neurological imaging in both clinical care and public health planning, reinforcing neurology as the primary application driving demand for cerebral angiography.

Cerebral Angiography Market- Geographical Insights

In the global cerebral angiography market, North America and Asia Pacific are notable leaders due to differences in healthcare infrastructure, disease prevalence, and technology adoption. North America holds the largest share, around 41.8 %, driven by advanced healthcare systems, widespread availability of neuroimaging technologies, and significant investment in diagnostic and interventional care for cerebrovascular diseases; the high incidence of stroke in the U.S. and Canada, combined with the extensive use of CT and MRI scanners, sustains demand for detailed vascular imaging. Asia Pacific, while smaller in current share, is experiencing rapid growth due to expanding healthcare infrastructure in countries like China and India, increasing awareness of stroke and neurovascular conditions, and government initiatives to improve access to advanced diagnostics, supported by large populations and a rising number of stroke cases. These trends highlight how healthcare capacity, disease burden, and public sector support influence the adoption and expansion of cerebral angiography across regions.

Cerebral Angiography Market- Country Insights

Worldwide, the United States maintains a strong presence in the cerebral angiography market, driven by the adoption of sophisticated neuroimaging tools and the need for detailed vascular diagnosis. The country faces a considerable burden of stroke and other cerebrovascular conditions; the Centre for Disease Control and Prevention (CDC) reports that over lakhs of people in the U.S. experience a stroke each year, including approximately lakhs of first-time strokes, with about 87 % being ischemic strokes that require precise imaging for effective treatment. These figures highlight the demand for cerebral angiography, which offers detailed visualization of brain blood vessels to detect abnormalities and assist in clinical decision-making. The combination of high disease prevalence, robust healthcare infrastructure, and access to advanced imaging systems reinforces the United States leading position in the global market.

Cerebral Angiography Market- Competitive Landscape:

In the competitive landscape of the cerebral angiography market, a number of established medical imaging and device companies offer advanced angiography systems, software, and supporting technologies for detailed visualization of cerebral blood vessels and efficient clinical workflows. Leading global players such as GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems are known for their comprehensive cerebral angiography solutions and continuous improvements in imaging quality and clinical support. Other important contributors, including Shimadzu Corporation, Boston Scientific Corporation, AngioDynamics, and Medtronic, add variety to the market with specialized products designed for diverse healthcare environments. These companies sustain their market presence through ongoing research and development, wide distribution channels, and product updates that address clinical demands, particularly for diagnosing and managing neurovascular diseases like stroke, which remains a priority for public health authorities and national healthcare planning.

Recent Developments:

In December 2025, Stratasys announced full commercial availability of its RadioMatrix radiopaque 3D printing material across the U.S., enabling healthcare providers and researchers to create patient-specific models with tunable X-ray visibility for imaging and training. This development is expected to enhance medical education, improve procedural planning, and support more accurate simulations, ultimately contributing to better patient outcomes and advancing innovation in medical imaging technologies.

In February 2025, the FDA granted 510(k) clearance to RapidAI's Lumina 3D software, which delivers AI-powered 3D CTA reconstructions of head and neck scans within minutes, improving visualization and accelerating neuroradiology workflow. This advancement is set to streamline diagnostic processes, enhance clinical decision-making, and support faster, more precise patient care in neuroradiology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CEREBRAL ANGIOGRAPHY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE Healthcare
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • Shimadzu Corp.
  • Canon Medical Systems Corporation
  • Samsung Medison
  • St. Jude Medical, Inc.
  • Hitachi Medical Corporation
  • TERUMO Corporation
  • Medtronic plc
  • Stryker Corporation
  • AngioDynamic, Inc.
  • Penumbra, Inc.
  • MicroPort Scientific Corporation
  • Cordis
  • Cook Medical LLC

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY IMAGING TECHNIQUE- MARKET ANALYSIS, 2020 - 2033

  • Digital Subtraction Angiography (DSA)
  • Magnetic Resonance Angiography (MRA)
  • Computed Tomography Angiography (CTA)
  • Catheter Angiography
  • Intraoperative Angiography

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Neurology
  • Neurosurgery
  • Interventional Radiology
  • Others

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY PATIENT AGE- MARKET ANALYSIS, 2020 - 2033

  • Adult Patients
  • Pediatric Patients

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY INDICATION- MARKET ANALYSIS, 2020 - 2033

  • Stroke
  • Aneurysm
  • Arteriovenous Malformation (AVM)
  • Carotid Artery Disease
  • Brain Tumors

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Hospitals
  • Diagnostic Imaging Centers
  • Specialty Neurology Clinics
  • Research Institution
  • Ambulatory Surgical Centers

GLOBAL CEREBRAL ANGIOGRAPHY MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cerebral Angiography Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cerebral Angiography Market Snippet by Imaging Technique
    • 2.1.2. Cerebral Angiography Market Snippet by Application
    • 2.1.3. Cerebral Angiography Market Snippet by Patient Age
    • 2.1.4. Cerebral Angiography Market Snippet by Indication
    • 2.1.5. Cerebral Angiography Market Snippet by End User
    • 2.1.6. Cerebral Angiography Market Snippet by Country
    • 2.1.7. Cerebral Angiography Market Snippet by Region
  • 2.2. Competitive Insights

3. Cerebral Angiography Key Market Trends

  • 3.1. Cerebral Angiography Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cerebral Angiography Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cerebral Angiography Market Opportunities
  • 3.4. Cerebral Angiography Market Future Trends

4. Cerebral Angiography Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cerebral Angiography Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cerebral Angiography Market Landscape

  • 6.1. Cerebral Angiography Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cerebral Angiography Market - By Imaging Technique

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Imaging Technique, 2025 & 2033 (%)
    • 7.1.2. Digital Subtraction Angiography (DSA)
    • 7.1.3. Magnetic Resonance Angiography (MRA)
    • 7.1.4. Computed Tomography Angiography (CTA)
    • 7.1.5. Catheter Angiography
    • 7.1.6. Intraoperative Angiography

8. Cerebral Angiography Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Neurology
    • 8.1.3. Neurosurgery
    • 8.1.4. Interventional Radiology
    • 8.1.5. Others

9. Cerebral Angiography Market - By Patient Age

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Patient Age, 2025 & 2033 (%)
    • 9.1.2. Adult Patients
    • 9.1.3. Pediatric Patients

10. Cerebral Angiography Market - By Indication

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Indication, 2025 & 2033 (%)
    • 10.1.2. Stroke
    • 10.1.3. Aneurysm
    • 10.1.4. Arteriovenous Malformation (AVM)
    • 10.1.5. Carotid Artery Disease
    • 10.1.6. Brain Tumors

11. Cerebral Angiography Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Hospitals
    • 11.1.3. Diagnostic Imaging Centers
    • 11.1.4. Specialty Neurology Clinics
    • 11.1.5. Research Institution
    • 11.1.6. Ambulatory Surgical Centers

12. Cerebral Angiography Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Cerebral Angiography Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Cerebral Angiography Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Cerebral Angiography Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Cerebral Angiography Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Cerebral Angiography Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Imaging Technique, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Patient Age, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Indication, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Cerebral Angiography Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
  • 13.3. GE Healthcare
  • 13.4. Siemens Healthineers
  • 13.5. Koninklijke Philips N.V.
  • 13.6. Shimadzu Corp.
  • 13.7. Canon Medical Systems Corporation
  • 13.8. Samsung Medison
  • 13.9. St. Jude Medical, Inc.
  • 13.10. Hitachi Medical Corporation
  • 13.11. TERUMO Corporation
  • 13.12. Medtronic plc
  • 13.13. Stryker Corporation
  • 13.14. AngioDynamic, Inc.
  • 13.15. Penumbra, Inc.
  • 13.16. MicroPort Scientific Corporation
  • 13.17. Cordis
  • 13.18. Cook Medical LLC

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제